Progress in tumour stem cell (TSC) biology has led to identification of cells possessing the specific characteristics of true glioma stem cells, specific markers (e.g. CD133), capacity for self-renewal and capacity for differentiation into the various cell lines of brain tissue (neuronal, glial) (Gilbertson and Rich, 2007). The gene discussed is PROM1; the disease is central nervous system cancer.